Digestive Diseases and Sciences

, Volume 34, Issue 4, pp 567–572 | Cite as

Effect of somatostatin analog (SMS 201-995) onin vivo intestinal fluid transport in rats

A limited systemic effect
  • Richard N. Fedorak
  • Sherie L. Allen
Original Articles
Received:
Revised:
Accepted:

Abstract

Somatostatin analog, SMS 201-995, effectively inhibits the release of hormones from gastrointestinal endocrine tumors and reduces hormonally mediated diarrheas. Its clinical efficacy in nonhormonally mediated diarrhea is limited, despite a potent antisecretory and proabsorptive effect in vitro. The effect of serosal addition of SMS 201-995 on in vitro short-circuit current responses in rat intestine is dependent upon chloride and more marked in colon and ileum than jejunum. In contrast, in vivo loop studies demonstrated that systemic administration of SMS 201-995 for five consecutive days produced a paradoxical decrease in basal colonic fluid absorption with no effect in jejunum or ileum. Furthermore, systemically administered SMS 201-995 did not alter cholera toxinstimulated intestinal secretion. We conclude that despite a previously identified intestinal antisecretory and proabsorptive effect of SMS 201-995 in vitro, this effect is not seen in vivo and may explain the limited use of SMS 201-995 as an antidiarrhoeal agent in nonhormonally mediated diarrhoea.

Key words

somatostatin analog SMS 201-995 intestine absorption cholera toxin diarrhea 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bauer W, Briner U, Doepfner W, Haller R, Huguenin R, Marboch P, Petcher TJ, Pless J: SMS 201-995: A very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci 31:1133–1140, 1982PubMedGoogle Scholar
  2. 2.
    Kutz K, Neusch E, Rosenthaler J: Pharmacokinetics of SMS 201-995 in healthy subjects. Scand J Gastroenterol 21:65–72, 1986PubMedGoogle Scholar
  3. 3.
    Roberts WG, Fedorak RN, Chang EB: In vitro effects of the long-acting somatostatin analogue SMS 201-995 on electrolyte transport by the rabbit ileum. Gastroenterology 94:1343–1350, 1988PubMedGoogle Scholar
  4. 4.
    Juby LD, Burke DA, Axon ATR: Somatostatin analogue SMS 201-995 long term therapy for vipoma. Postgrad Med J 63:287–289, 1987PubMedGoogle Scholar
  5. 5.
    Edwards C, Cann PA, Read NW, Holdsworth CD: Effect of two new antisecretory drugs on fluid and electrolyte transport in a patient with secretory diarrhoea. Gut 27:581–585, 1986PubMedGoogle Scholar
  6. 6.
    Smith SS, Shulman DI, O'Dorisio TM, McClenathan DT, Borger JA, Bercu BB, Root AW: Watery diarrhea, hypokalemia, achlorhydria syndrome in an infant: Effect of the long-acting somatostatin analogue SMS 201-995 on the disease and linear growth. J Pediatr Gastroenterol Nutr 6:710–716, 1987PubMedGoogle Scholar
  7. 7.
    Vinik, AI, Tsai ST, Moattari AR, Cheung P, Eckhauser FE, Cho K: Somatostatin analogue (SMS 201-995) in the management of gastroenteropancreatic tumors and diarrhea syndromes. Am J Med 81:23–40, 1986Google Scholar
  8. 8.
    Maton PN, O'Dorisio TM, Brent A, Howe BA, McArthur KE, Howard JM, Cherner JA, Malarkey TB, Collen MJ, Gardner JD, Jensen RT: Effect of a long-acting somatostatin analog (201-995) in a patient with pancreatic cholera. N Engl J Med 312:17–21, 1985PubMedGoogle Scholar
  9. 9.
    Jaros W, Biller J, Greer S, O'Dorisio T, Grand R: Successful treatment of ideopathic secretory diarrhea of infancy with the somatostatin analogue SMS 201-995. Gastroenterology 94:189–193, 1988PubMedGoogle Scholar
  10. 10.
    Santangelo WC, O'Dorisio TM, Kim JG, Severino G, Krejs GJ: Pancreatic cholera syndrome: Effect of a synthetic somatostatin analog on intestinal water and ion transport. Ann Intern Med 103:363–367, 1985PubMedGoogle Scholar
  11. 11.
    Cook DJ, Kelton JG, Stanisz AM, Collins SM: Somatostatin treatment for cryptosporidial diarrhea in a patient with acquired immunodeficiency syndrome. Ann Intern Med 108:708–709, 1988PubMedGoogle Scholar
  12. 12.
    Mulvhill S, Passaro E, Debas H, Yamada T: Severe diarrhea after colonic pseudo-obstruction: Treatment with somatostatin. N Engl J Med 310:467–468, 1984PubMedGoogle Scholar
  13. 13.
    Cooper JC, Williams NS, King RFGJ, Barker MCJ: Effects of a long-acting somatostatin analogue in patients with severe ileostomy diarrhoea. Br J Surg 73:128–131, 1986PubMedGoogle Scholar
  14. 14.
    Fedorak RN: Effect of somatostatin analog (SMS 201-995) in diarrhea associated with inflammatory bowel disease. Can J Gastroenterol (in press)Google Scholar
  15. 15.
    Chang EB, Fedorak RN, Field M: Experimental diabetic diarrhea in rats. Intestinal mucosal denervation and hypersensitivity and treatment with clonidine. Gastroenterology 91:564–569, 1986PubMedGoogle Scholar
  16. 16.
    Field M, Fromm D, McColl I: Ion transport in rabbit ileal mucosa. I. Na and Cl fluxes and short-circuit current. Am J Physiol 220:1388–1394, 1971PubMedGoogle Scholar
  17. 17.
    Chang EB, Bergenstal RM, Field M: Diarrhea in streptozocintreated rats. Loss of adrenergic regulation of intestinal fluid and electrolyte transport. J Clin Invest 75:1666–1670, 1985PubMedGoogle Scholar
  18. 18.
    Guandalini S, Kachur JF, Smith PL, Miller RJ, Field M:In vitro effects of somatostatin on ion transport in rabbit intestine. Am J Physiol 238:G67-G74, 1980PubMedGoogle Scholar
  19. 19.
    Fedorak RN, Kotake A, Douglas F, Chang EB: Inhibition of cholera toxin-stimulated intestinal secretion by CGS 9343B in rats: A specific calmodulin inhibitor. Pediatr Gastroenterol Nutr (in press)Google Scholar
  20. 20.
    Dharmsathaphorn K, Sherwin RS, Dobbins JW: Somatostatin inhibits fluid secretion in the rat jejunum. Gastroenterology 78:1554–1558, 1980PubMedGoogle Scholar
  21. 21.
    Dharmsathaphorn K, Binder HJ, Dobbins JW: Somatostatin stimulates sodium and chloride absorption in the rabbit ileum. Gastroenterology 78:1559–1565, 1980PubMedGoogle Scholar
  22. 22.
    Dharmsathaphorn K, Racusen L, Dobbins JW: Somatostatin (SRIF) alters electrolyte transport in the rat colon. Gastroenterology 76:121, 1979Google Scholar
  23. 23.
    Keast JR, Furness JB, Costa M: Somatostatin in human enteric nerves. Distribution and characterization. Cell Tissue Res 237:299–308, 1984PubMedGoogle Scholar
  24. 24.
    Bloom SR, Polak JM: Somatostatin.In Gut Hormones. SR Bloom (ed). Edinburgh, Churchill Livingston, 1978, pp 3–18Google Scholar
  25. 25.
    Srikant CB, Patel YC: Receptor binding of somatostatin-28 is tissue specific. Nature 294:259–260, 1981PubMedGoogle Scholar
  26. 26.
    Srikant CB, Patel YC: somatostatin receptors in the rat adrenal cortex: Characterization and comparison with brain and pituitary receptors. Endocrinology 116:1717–1723, 1985PubMedGoogle Scholar
  27. 27.
    Tran VT, Beal MF, Martin JB: Two types of somatostatin receptors differentiated by cyclic somatostatin analogues. Science 228:492–495, 1985PubMedGoogle Scholar
  28. 28.
    Plewe G, Krause U, Beyon J, Neufeld M, del Pozo E: Long-acting and selective suppression of growth hormone secretion by somatostatin analogue SMS 201-995 in acromegaly. Lancet 2:782–784, 1984PubMedGoogle Scholar
  29. 29.
    Lamberts SWJ, Verleun T, Oosterom R: Somatostatin analogue SMS 201-995 increases long-acting inhibition of growth hormone without rebound hypersecretion in acromegalic patients. J Clin Endocrinol Metab 58:250–255, 1984PubMedGoogle Scholar
  30. 30.
    Wahren J, Felig P: Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus. Lancet 2:1213–1216, 1976PubMedGoogle Scholar
  31. 31.
    Baskin DG, Ensinck JW: Somatostatin in epithelial cells of intestinal mucosa is present primarily as somatostatin-28. Peptides 5:615–621, 1984PubMedGoogle Scholar
  32. 32.
    Evensen D, Hansson KF, Benstad A: The effect on intestinal calcium absorption of somatostatin in man. Scand J Gastroenterol 13:449–451, 1978PubMedGoogle Scholar
  33. 33.
    Krejs GH, Browne R, Raskin P: The effect of intravenous somatostatin on jejunal absorption of glucose, amino acids, water and electrolytes. Gastroenterology 78:26–31, 1980PubMedGoogle Scholar
  34. 34.
    Dueno MI, Bai JC, Santangelo WC, Krejs GJ: Effect of somatostatin analog on water and electrolyte transport and transit time in human small bowel. Dig Dis Sci, 32:1096–1096, 1987Google Scholar
  35. 35.
    Sonnenberg GE, Keller U, Perruchoud A, Burckhardt D, Gyr K: Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects. Gastroenterology 80:526–532, 1981PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1989

Authors and Affiliations

  • Richard N. Fedorak
    • 1
  • Sherie L. Allen
    • 1
  1. 1.Department of Medicine, Division of GastroenterologyThe University of AlbertaEdmontonCanada

Personalised recommendations